Targeting cognition in schizophrenia research: from etiology to treatment

Am J Psychiatry. 2009 Jun;166(6):631-4. doi: 10.1176/appi.ajp.2009.09040497.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Amisulpride
  • Antipsychotic Agents / pharmacology*
  • Antipsychotic Agents / therapeutic use*
  • Benzodiazepines / pharmacology
  • Benzodiazepines / therapeutic use
  • Cognition / drug effects
  • Cognition Disorders / diagnosis
  • Cognition Disorders / etiology*
  • Dibenzothiazepines / pharmacology
  • Dibenzothiazepines / therapeutic use
  • Drug Administration Schedule
  • Haloperidol / pharmacology
  • Haloperidol / therapeutic use
  • Humans
  • Olanzapine
  • Piperazines / pharmacology
  • Piperazines / therapeutic use
  • Quetiapine Fumarate
  • Reaction Time / drug effects
  • Schizophrenia / complications*
  • Schizophrenia / drug therapy*
  • Sulpiride / analogs & derivatives
  • Sulpiride / pharmacology
  • Sulpiride / therapeutic use
  • Thiazoles / pharmacology
  • Thiazoles / therapeutic use

Substances

  • Antipsychotic Agents
  • Dibenzothiazepines
  • Piperazines
  • Thiazoles
  • Benzodiazepines
  • Quetiapine Fumarate
  • ziprasidone
  • Sulpiride
  • Amisulpride
  • Haloperidol
  • Olanzapine